Kite Pharma
Kite Pharma is a California-based biotechnology company that researches and develops cell-based immunotherapies for the treatment of cancer.
Business Model:
Revenue: $45M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Kite Pharma Information
Kite Pharma was acquired by
Gilead Sciences.
The acquisition happend on 2017-08-28.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 2400 Broadway
City: Santa Monica
State: CA
Zip: 90404
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$250M
Raised Total:$335M
Social
Metrics
1,265,405Website Global Rank
23,172Website Monthly Traffic
Twitter Followers
Description
Kite Pharma is a California-based biotechnology company that researches and develops cell-based immunotherapies for the treatment of cancer.
Contact Phone:
+13108249999
Contact Email:
Kite Pharma went public on 6/27/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/27/2014
IPO Valuation:
$625M
Ticker Symbol:
KITE
IPO Price:
$17/share
Amount Raised:
$127M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2021 | Shoreline Biosciences | Series A | 0 |
| 8/2019 | HiFiBiO | Series C | 0 |
| 7/2022 | AlloVir | Post-IPO Equity | 0 |
| 6/2016 | Cell Design Labs | Equity | 34.4M |
| 11/2021 | Shoreline Biosciences | Series B | 0 |
| 7/2020 | Fosun Kite Biotechnology | Corporate Round | 0 |
| 7/2018 | Gadeta | Funding Round | - |
| 12/2022 | Arcellx | Post-IPO Equity | 100M |
| 2/2021 | Orna Therapeutics | Series A | 0 |
| 2/2020 | Vineti | Series C | 35M |
| 7/2018 | Gadeta | Corporate Round | - |
| 7/2022 | AlloVir | Post-IPO Equity | 0 |
| 11/2021 | Shoreline Biosciences | Series B | 0 |
| 2/2021 | Orna Therapeutics | Series A | 0 |
| 2/2021 | Shoreline Biosciences | Series A | 0 |
| 7/2020 | Fosun Kite Biotechnology | Corporate Round | 0 |
| 2/2020 | Vineti | Series C | 0 |
| 8/2019 | HiFiBiO | Series C | 0 |
| 7/2018 | Gadeta | Funding Round | - |
| 6/2016 | Cell Design Labs | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2013 | Series A | 2 | $20M |
Two River Alta Partners Alta Partners Two River Alta Partners Alta Partners |
5/2014 | Debt Financing | 1 | $50M |
Arie Belldegrun Arie Belldegrun |
12/2012 | Debt Financing | $250k | 12/2015 | Post-IPO Equity | $250.1M | 5/2013 | Series A | $35M |
Alta Partners Commercial Street Capital |
3/2011 | Series A | 2 | $15M |
Two River Riverbank Capital Securities Two River Riverbank Capital Securities |
11/2012 | Debt | $250k |
TPG Capital Vida Ventures, LLC |
3/2017 | Post-IPO Equity | $409.7M | 4/2014 | Debt | $50M |
TPG Capital Vida Ventures, LLC |
6/2014 | IPO | $127.5M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
